Showing results (171-180 of 390) with videos related to

Sort By:
Pageof 39
Plos One|February 19, 2013
Relationships between mitochondrial function and metabolic flexibility in type 2 diabetes mellitusTineke van de Weijer, Lauren Marie Sparks, Esther Phielix, et al.
European Heart Journal|December 1, 1988
Effect of combining electrocardiographic interpretation results on diagnostic accuracyJ L Willems, C Abreu-Lima, P Arnaud, et al.
Targeted Oncology|January 22, 2014
A phase II study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural effusionS F Mulder, M J Boers-Sonderen, H F M van der Heijden, et al.
Journal of Electrocardiology|October 1, 1987
Testing the performance of ECG computer programs: the CSE diagnostic pilot studyJ L Willems, C Abreu-Lima, P Arnaud, et al.
Current Medical Research and Opinion|October 4, 2005
Differences between statins on clinical endpoints: a population-based cohort studyJeanne P Dieleman, Jacobus T van Wyk, Marc A M van Wijk, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|October 12, 2020
Cardiac Function and Ventricular Interactions in Persistent Pulmonary Hypertension of the NewbornAmish Jain, Afif F El-Khuffash, Claar H van Herpen, et al.
Psycho-Oncology|September 12, 2023
The solitary versus supported experience: Care inequality between rare and common cancer patientsEline de Heus, Kalinka van de Camp, Esmee Driehuis, et al.
British Journal of Cancer|September 30, 2010
A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumoursC M L van Herpen, F A L M Eskens, M de Jonge, et al.
Cancer Treatment Reviews|January 13, 2009
Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapyI M E Desar, C M L van Herpen, H W M van Laarhoven, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 25, 2013
18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcomeBianca A W Hoeben, Esther G C Troost, Paul N Span, et al.
Pageof 39